Jesica Mazza Stalder

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


35 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2005 | 2003 |
2024
Correction to: Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study.
Andenmatten S., Opota O., Mazza-Stalder J., Nicod L., Greub G., Jaton K., 2024/06. European journal of clinical microbiology & infectious diseases, 43 (6) p. 1259. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4A965E41817]
2023
 
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.
Global Tuberculosis Network and TB/COVID-19 Global Study Group, Casco N., Jorge A.L., Palmero D.J., Alffenaar J.W., Fox G.J., Ezz W., Cho J.G., Denholm J., Skrahina A. et al., 2023/11. The European respiratory journal, 62 (5) p. 2300925. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C73E5F757E12]
Performance of microbiological tests for tuberculosis diagnostic according to the type of respiratory specimen: A 10-year retrospective study.
Boldi M.O., Denis-Lessard J., Neziri R., Brouillet R., von-Garnier C., Chavez V., Mazza-Stalder J., Jaton K., Greub G., Opota O., 2023. Frontiers in cellular and infection microbiology, 13 p. 1131241. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F4A71366B41B]
2022
 
A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
Mercier T., Desfontaine V., Cruchon S., Da Silva Pereira Clara J.A., Briki M., Mazza-Stalder J., Kajkus A., Burger R., Suttels V., Buclin T. et al., 2022/11/15. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1211 p. 123456. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8BD27ECE6B02]
 
Prise en charge de maladies infectieuses auprès des requérants d’asile et détenus vaudois
Chastonay Oriane, Masserey Éric, Dory Élodie, Beaupere Pascale, Mazza-Stalder Jesica, De Vallière Serge, L'hostis Yann, Bodenmann Patrick, 2022. pp. 493-505 dans Bodenmann Patrick, Jackson Yves, Vu Francis, Wolff Hans (eds.) Vulnérabilités, diversités et équité en santé chap. 3.4, RMS éditions / Médecine et Hygiène.
[serval:BIB_580556C980FF]
Successful pregnancy in a cystic fibrosis patient with a severe impairment of lung function receiving Elexacaftor-Tezacaftor-Ivacaftor.
Balmpouzis Z., Faure van Rossum A., Baud D., Panchaud A., Mitropoulou G., Mazza Stalder J., Koutsokera A., 2022. Respiratory medicine case reports, 40 p. 101776. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_40C6261EB44B]
2021
Editorial: Tuberculosis and Non-tuberculous Mycobacteria Infections: Control, Diagnosis and Treatment.
Opota O., Mazza-Stalder J., Viveiros M., Cambau E., Santin M., Goletti D., 2021. Frontiers in public health, 9 p. 666187. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D1B12026BB66]
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.
Koirala S., Borisov S., Danila E., Mariandyshev A., Shrestha B., Lukhele N., Dalcolmo M., Shakya S.R., Miliauskas S., Kuksa L. et al., 2021. Pulmonology, 27 (5) pp. 403-412. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_94A292ABD73B]
2020
Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
Laurent S., Zakham F., Bertelli C., Merz L., Nicod L., Mazza-Stalder J., Greub G., Jaton K., Opota O., 2020/08. International journal of antimicrobial agents, 56 (2) p. 106068. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_81020030909E]
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Tadolini M., Codecasa L.R., García-García J.M., Blanc F.X., Borisov S., Alffenaar J.W., Andréjak C., Bachez P., Bart P.A., Belilovski E. et al., 2020/07. The European respiratory journal, 56 (1). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4A0EAE45C82A]
Multicenter analysis of sputum microbiota in tuberculosis patients.
Sala C., Benjak A., Goletti D., Banu S., Mazza-Stalder Jesica, Jaton K., Busso P., Remm S., Leleu M., Rougemont J. et al., 2020. PloS one, 15 (10) pp. e0240250. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E924DB344DCF]
2019
 
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
Borisov S., Danila E., Maryandyshev A., Dalcolmo M., Miliauskas S., Kuksa L., Manga S., Skrahina A., Diktanas S., Codecasa L.R. et al., 2019/12. The European respiratory journal, 54 (6) p. 1901522. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_92C1E415B7A3]
The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection.
Opota O., Mazza-Stalder J., Greub G., Jaton K., 2019/11. Clinical microbiology and infection, 25 (11) pp. 1370-1376. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AB65E37DF14D]
Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study.
Andenmatten S., Onya O., Mazza-Stalder J., Nicod L., Gilbert G., Katia J., 2019/10. European journal of clinical microbiology & infectious diseases, 38 (10) pp. 1873-1881. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1FCD4700BC84]
Whole-genome sequencing for rapid, reliable and routine investigation of Mycobacterium tuberculosis transmission in local communities.
Zakham F., Laurent S., Esteves Carreira A.L., Corbaz A., Bertelli C., Masserey E., Nicod L., Greub G., Jaton K., Mazza-Stalder J. et al., 2019/09. New microbes and new infections, 31 p. 100582. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_604EC4A7CD3F]
Consensus vaudois de prise en charge de maladies infectieuses auprès des requérants d’asile et détenus [Consensus for the management of infectious diseases among asylum seekers and detainees in the canton of Vaud]
Chastonay O., Masserey É., Dory É., Beaupère P., Mazza-Stalder J., De Vallière S., L'hostis Y., Bodenmann P., 2019/02/27. Revue medicale suisse, 15 (640) pp. 466-472. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_2BE1D6FDDDA3]
Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting.
Opota O., Zakham F., Mazza-Stalder J., Nicod L., Greub G., Jaton K., 2019/02. Journal of clinical microbiology, 57 (2). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7A47A167126E]
Improvement in Tuberculosis Outcomes With a Combined Medical and Social Approach.
Mazza-Stalder J., Chevallier E., Opota O., Carreira A., Jaton K., Masserey E., Zellweger J.P., Nicod L.P., 2019. Frontiers in medicine, 6 p. 135. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_11F402645AE4]
2018
Health-seeking behaviour and treatment delay in patients with pulmonary tuberculosis in Switzerland: some slip through the net.
Auer C., Kiefer S., Zuske M., Schindler C., Wyss K., Blum J., Bosch-Capblanch X., Widmer U., Sauthier S., Janssens J.P. et al., 2018/08/27. Swiss medical weekly, 148 pp. w14659. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_294A9C1FD108]
2016
Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
Opota O., Senn L., Prod'hom G., Mazza-Stalder J., Tissot F., Greub G., Jaton K., 2016/07. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 22 (7) pp. 613-619. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8C3FAFE42703]
 
Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country.
Stucki D., Ballif M., Egger M., Furrer H., Altpeter E., Battegay M., Droz S., Bruderer T., Coscolla M., Borrell S. et al., 2016/07. Journal of clinical microbiology, 54 (7) pp. 1862-1870. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A3A0FD5BC136]
2015
Combined Use of Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses Is a Powerful Diagnostic Tool of Active Tuberculosis.
Rozot V., Patrizia A., Vigano S., Mazza-Stalder J., Idrizi E., Day C.L., Perreau M., Lazor-Blanchet C., Ohmiti K., Goletti D. et al., 2015. Clinical Infectious Diseases, 60 (3) pp. 432-437. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_35203E0F848B]
2014
 
Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study.
Bridevaux P.O., Aubert J.D., Soccal P.M., Mazza-Stalder J., Berutto C., Rochat T., Turin L., Belle S.V., Nicod L., Meylan P. et al., 2014. Thorax, 69 (1) pp. 32-38. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_62F8485E762C]
2013
 
Combined analysis of mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses for the timely diagnosis of active TB disease.
Rozot V, Vigano S, Mazza-Stalder J, Idrizi E, Day C, Perreau M, Lazor-Blanchet C, Petruciolli E, Hanekom W, Goletti D et al., 2013/04/18., Société Suisse d’allergologie et Société Suisse de penumologie dans Congrès annuel de la Société Suisse d’allergologie et Société Suisse de penumologie / Présentation orale / Laboratory diagnostic / 2013 Bern.
[serval:BIB_03E563DA8898]
 
Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4(+) T cells in active disease.
Perreau M., Rozot V., Welles H.C., Belluti-Enders F., Vigano S., Maillard M., Dorta G., Mazza-Stalder Jesica, Bart P.A., Roger T. et al., 2013. European Journal of Immunology, 43 (4) pp. 939-948.
[DOI][WoS][Pmid][serval:BIB_E956D462F256]
2012
 
La tuberculose extrapulmonaire [Extrapulmonary tuberculosis].
Mazza-Stalder J., Nicod L., Janssens J.P., 2012. Revue des Maladies Respiratoires, 29 (4) pp. 566-578. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_70207CBD9621]
 
Mycobacterium tuberculosis-specific CD8 T cells are functionally and phenotypically different between latent infection and active disease
Rozot V., Vigano S., Mazza-Stalder J., Perreau M., Goletti D., Bart P. A., Nicod L., Pantaleo G., Harari A., 2012. p. 598 dans European Congress of Immunology, Immunology.
[WoS][serval:BIB_D7303CF13CEC]
2011
 
Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient.
Boillat Blanco N., Kuonen R., Bellini C., Manuel O., Estrade C., Mazza-Stalder J., Aubert J.D., Sahli R., Meylan P., 2011. Transplant Infectious Disease, 13 (2) pp. 213-215.
[DOI][Pmid][serval:BIB_AFC324683A49]
Infection latente a M. tuberculosis, mise a jour 2011 [Latent M. tuberculosis infection, update 2011].
Lechartier B., Mazza-Stalder J., Janssens J.P., Nicod L.P., 2011. Revue Médicale Suisse, 7 (318) pp. 2289-2294. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_247DB65224E5]
 
Successful bilateral lung transplantation after previous pneumonectomy
Gonzalez M., Ris H.B., Krueger T., Ferrari E., Chollet-Rivier M., Marcucci C., Prior J.O., Jayet P.Y., Mazza-Stalder J., Aubert J.D., 2011. pp. 21-22 dans 98th Annual Congress of the Swiss Society of Surgery, British Journal of Surgery. Peer-reviewed.
[WoS][serval:BIB_E6CA62ABE997]
2010
Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy.
Uçkay I., Gasche-Soccal P.M., Kaiser L., Stern R., Mazza-Stalder J., Aubert J.D., van Delden C., 2010/03. The Journal of heart and lung transplantation, 29 (3) pp. 299-305. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F4DDBA4898BF]
2009
 
Mycobactéries non tuberculeuses maladie pulmonaire: quoi de neuf [Non tuberculous mycobacteria pulmonary disease: what's new?].
Mazza-Stalder J., Jaton-Ogay K., Nicod L., 2009. Revue Médicale Suisse, 5 (226) pp. 2344-2350.
[Pmid][serval:BIB_B0B59500A288]
2005
 
Immunisation, immunomodulation et prévention des infections respiratoires [Immunization and immuno-modulation for prevention of respiratory tract infections]
Mazza-Stalder J., Siegrist C.A., Janssens J.P., 2005/11/16. Revue medicale suisse, 1 (41) pp. 2645-2646,2649-2651. Peer-reviewed.
[Pmid][serval:BIB_5BBCF3153619]
2003
 
Le syndrome hépatopulmonaire (SHP)
Mazza-Stalder Jesica, Sauty Alain, 2003/11/01. Rev Med Suisse, 1 (2458) p. 23390.
[serval:BIB_02FC9C7170BE]
 
Abstracts
Sauty A., Mazza-Stalder J., Ruiz J., Hofer M., Roulet M., 2003/06. pp. 3-112 dans Journal of Cystic Fibrosis, Journal of Cystic Fibrosis. Peer-reviewed, Elsevier BV.
[DOI][serval:BIB_E94BB639DE43]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University